Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesssupramolecular fiber organization

SHANK1 FLNA SHROOM3 MYH11 RIPK3 CLASP1 NDE1 KRT28 KRT84 KRT85 WASHC1 APC USH1C MAP3K1 SPTBN4 BMP1 MYO1F KRT20 ELN CCL21 SAMD14

1.25e-0595715721GO:0097435
GeneOntologyBiologicalProcessmaintenance of synapse structure

SHANK1 CBLN3 NLGN1 NRXN1 APPL1

1.27e-05401575GO:0099558
GeneOntologyBiologicalProcessregulation of presynaptic active zone assembly

NLGN1 NRXN1

5.76e-0521572GO:1905518
GeneOntologyBiologicalProcesspositive regulation of presynaptic active zone assembly

NLGN1 NRXN1

5.76e-0521572GO:1905520
GeneOntologyBiologicalProcesscell-cell adhesion involved in synapse maturation

NLGN1 NRXN1

5.76e-0521572GO:0090125
GeneOntologyBiologicalProcessregulation of plasma membrane bounded cell projection organization

SEMA6C ACSL6 FLNA EPS8L2 RAP1GAP WASHC1 APC GRIN1 NLGN1 DCC USH1C PLXNB2 GSK3A NRXN1 CAPRIN2 EIF4G2 CCL21 BRSK1

8.11e-0584615718GO:0120035
GeneOntologyBiologicalProcessimmunoglobulin production

TCF3 IGLV5-37 IGLV4-69 IGLV2-23 MCM3AP IGKV3D-7 IGKV2D-28 IGKV3-20 IGKV2-28

9.87e-052411579GO:0002377
GeneOntologyBiologicalProcessregulation of cell projection organization

SEMA6C ACSL6 FLNA EPS8L2 RAP1GAP WASHC1 APC GRIN1 NLGN1 DCC USH1C PLXNB2 GSK3A NRXN1 CAPRIN2 EIF4G2 CCL21 BRSK1

1.04e-0486315718GO:0031344
GeneOntologyBiologicalProcesspositive regulation of cell projection organization

ACSL6 FLNA EPS8L2 WASHC1 APC GRIN1 NLGN1 DCC PLXNB2 NRXN1 CAPRIN2 EIF4G2 CCL21

1.08e-0449415713GO:0031346
GeneOntologyBiologicalProcesspositive regulation of pseudopodium assembly

WASHC1 APC CCL21

1.17e-04131573GO:0031274
GeneOntologyBiologicalProcessregulation of pseudopodium assembly

WASHC1 APC CCL21

1.17e-04131573GO:0031272
GeneOntologyBiologicalProcesscellular component maintenance

SHANK1 CBLN3 GRIN1 NLGN1 NRXN1 APPL1

1.23e-041011576GO:0043954
GeneOntologyBiologicalProcesscell junction maintenance

SHANK1 CBLN3 NLGN1 NRXN1 APPL1

1.37e-04651575GO:0034331
GeneOntologyBiologicalProcesspositive regulation of exocytosis

CLASP1 EXPH5 NLGN1 SYT10 CACNA1I RAB27A

1.70e-041071576GO:0045921
GeneOntologyBiologicalProcessregulation of neuromuscular synaptic transmission

NLGN1 NRXN1

1.72e-0431572GO:1900073
GeneOntologyBiologicalProcesspositive regulation of neuromuscular synaptic transmission

NLGN1 NRXN1

1.72e-0431572GO:1900075
GeneOntologyBiologicalProcesspseudopodium assembly

WASHC1 APC CCL21

2.72e-04171573GO:0031269
GeneOntologyCellularComponentaxon

MYC FLNA RAP1GAP CDHR3 APC GRIN1 DCC GSK3A EXOC8 SPTBN4 HMCN2 KCNA6 NRXN1 PTPRN2 EIF4G2 KCNK2 WDFY3 TMEM151A BRSK1

5.35e-0589116019GO:0030424
GeneOntologyCellularComponentsynaptic cleft

CBLN3 CDHR3 GRIN1 NLGN1

1.14e-04331604GO:0043083
GeneOntologyCellularComponentimmunoglobulin complex

IGLV5-37 IGLV4-69 IGLV2-23 IGKV3D-7 IGKV2D-28 IGKV3-20 IGKV2-28

2.96e-041661607GO:0019814
GeneOntologyCellularComponentaxonal growth cone

FLNA APC DCC NRXN1

3.86e-04451604GO:0044295
GeneOntologyCellularComponentextracellular matrix

COL20A1 COL6A5 ADAMTS8 GDF10 PLXNB2 ITGB4 SNED1 BMP1 LRIG3 HMCN2 ELANE ELN DMBT1 VWA2

5.34e-0465616014GO:0031012
GeneOntologyCellularComponentdistal axon

FLNA CDHR3 APC GRIN1 DCC EXOC8 KCNA6 NRXN1 PTPRN2 KCNK2 BRSK1

5.41e-0443516011GO:0150034
GeneOntologyCellularComponentpolymeric cytoskeletal fiber

FLNA SHROOM3 KIF27 CLASP1 NDE1 KRT28 KRT84 KRT85 APC SRPRB GSK3A MAP3K1 SMTN SPTBN4 MYO1F KRT20 TTLL1

5.45e-0489916017GO:0099513
GeneOntologyCellularComponentexternal encapsulating structure

COL20A1 COL6A5 ADAMTS8 GDF10 PLXNB2 ITGB4 SNED1 BMP1 LRIG3 HMCN2 ELANE ELN DMBT1 VWA2

5.50e-0465816014GO:0030312
GeneOntologyCellularComponentcell cortex

FLNA SHROOM3 CLASP1 WASHC1 APC ITGB4 EXOC8 SPTBN4 HMCN2 MYO1F

5.93e-0437116010GO:0005938
GeneOntologyCellularComponentsupramolecular fiber

FLNA SHROOM3 MYH11 KIF27 CLASP1 NDE1 KRT28 KRT84 KRT85 APC SRPRB GSK3A MAP3K1 SMTN SPTBN4 MYO1F KRT20 TTLL1 ELN AHNAK2

6.97e-04117916020GO:0099512
GeneOntologyCellularComponentsupramolecular polymer

FLNA SHROOM3 MYH11 KIF27 CLASP1 NDE1 KRT28 KRT84 KRT85 APC SRPRB GSK3A MAP3K1 SMTN SPTBN4 MYO1F KRT20 TTLL1 ELN AHNAK2

7.58e-04118716020GO:0099081
GeneOntologyCellularComponentcollagen-containing extracellular matrix

COL20A1 COL6A5 ADAMTS8 GDF10 PLXNB2 ITGB4 BMP1 HMCN2 ELANE ELN DMBT1 VWA2

8.05e-0453016012GO:0062023
GeneOntologyCellularComponentprotein complex involved in cell-cell adhesion

NLGN1 NRXN1

8.56e-0461602GO:0098635
GeneOntologyCellularComponentexcitatory synapse

SHANK1 CBLN3 GRIN1 NLGN1 NRXN1

1.40e-031071605GO:0060076
GeneOntologyCellularComponentIgM immunoglobulin complex, circulating

IGKV3D-7 IGKV3-20

1.58e-0381602GO:0071754
GeneOntologyCellularComponentpentameric IgM immunoglobulin complex

IGKV3D-7 IGKV3-20

1.58e-0381602GO:0071756
GeneOntologyCellularComponentmonomeric IgA immunoglobulin complex

IGKV3D-7 IGKV3-20

2.02e-0391602GO:0071748
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

SHANK1 SHROOM3 PDE4A CLASP1 BCLAF1 DNAJA2 APC TNRC6B DIDO1 GRIN1 ARMCX4 LUZP1 SPTBN4 NRXN1 PTPRN2 YLPM1 APPL1 WDFY3 BRSK1 THRAP3 WNK2

6.95e-099631652128671696
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

TUT4 SETD1B BCLAF1 USP24 APC CPD IRS1 ADAMTS8 ADAM12 PLXNB2 GSK3A CES2 PPIL2 ECEL1 KAT6B THRAP3 WNK2

8.25e-087301651734857952
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ACSL6 SETD1B CLASP1 SPEG TNRC6B NLGN1 ARHGEF17 LRIG3 MCM3AP ASXL2 RAB11FIP4 VPS13B

6.34e-074071651212693553
Pubmed

Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

SEMA6C SRRM4 MYO15B CAPRIN2 HHIPL1 RAB11FIP4 BRSK1

8.34e-07107165711347906
Pubmed

Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol.

MYC APC GSK3A

2.08e-066165320729907
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

SHANK1 FLNA TUT4 CPSF6 BCLAF1 DNAJA2 USP24 APC TNRC6B GRIN1 SRPRB GSK3A SAFB NRXN1 EIF4G2 APPL1 DNAJB2 THRAP3 WNK2

2.20e-0611391651936417873
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CRTC3 ZNF326 SHROOM3 RAP1GAP CLASP1 EXPH5 PPP1R3E ANKRD26 APC IRS1 ARHGEF17 GSK3A LUZP1 CLK3 CCDC102A AHNAK2

3.82e-068611651636931259
Pubmed

A human MAP kinase interactome.

SHANK1 MYC FLNA CRTC3 MYH11 EXPH5 APC ITGB4 MCM3AP KRT20 WASH2P WNK2

3.97e-064861651220936779
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

FLNA CLASP1 BCLAF1 USP24 DIDO1 GSK3A SMTN PDIA6 SAFB YLPM1 EIF4G2 APPL1 KAT6B MN1 THRAP3

4.72e-067741651515302935
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

EXPH5 ANKRD26 APC TNRC6B CPD ZDHHC8 PDIA6 VPS13B AHNAK2

5.06e-06263165934702444
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

SEMA6C FLNA SHROOM3 PDE4A SETD1B SPEG TBC1D25 IRS1 PLXNB2 ZDHHC8 ITGB4 AHDC1 SARS2 MCM3AP WDFY3 ELL WNK2 AHNAK2

5.74e-0611051651835748872
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SEMA6C SHROOM3 BCLAF1 SRRM4 DIDO1 LRIG3 PLCH2 CAPRIN2 HHIPL1 KAT6B MINDY1 WNK2

9.32e-065291651214621295
Pubmed

Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.

TCF3 EPS8L2 RAP1GAP TUT4 CPSF6 DIDO1 TBC1D25 CPD PLXNB2 ITGB4 SMTN SAFB SARS2 CLK3 DMBT1 THRAP3

9.36e-069251651628986522
Pubmed

An unappreciated role for RNA surveillance.

PDE4A FTCD USH1C BMP1 CLK3 DNAJB2

9.62e-06102165614759258
Pubmed

Identification of proximal SUMO-dependent interactors using SUMO-ID.

FLNA TNRC6B AHDC1 LUZP1 SMTN SAFB DACH2 EIF4G2 PPIL2 CCDC102A AHNAK2

9.82e-064441651134795231
Pubmed

Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

SETD1B USP24 ANKRD26 TNRC6B NLGN1 PDZRN3

1.08e-05104165610470851
Pubmed

The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc.

MYC APC GSK3A

1.23e-0510165319131971
Pubmed

Behavioral phenotypes of genetic mouse models of autism.

SHANK1 NLGN1 NRXN1

1.68e-0511165326403076
Pubmed

High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.

ACSL6 CRTC3 TUT4 NDE1 DNAJA2 TNRC6B PLXNB2 PPIL2 THRAP3

1.74e-05307165937499664
Pubmed

Studies of the interactions between the anticytokeratin 8 monoclonal antibody TS1, its antigen and its anti-idiotypic antibody alphaTS1.

IGKV2D-28 IGKV2-28

2.24e-052165212833571
Pubmed

IRS1/β-Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells.

MYC IRS1

2.24e-052165227987331
Pubmed

Two V kappa germ-line genes related to the GAT idiotypic network (Ab1 and Ab3/Ab1') account for the major subfamilies of the mouse V kappa-1 variability subgroup.

IGKV2D-28 IGKV2-28

2.24e-05216523100621
Pubmed

Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin/neuroligin contacts.

NLGN1 NRXN1

2.24e-052165219098102
Pubmed

DCC constrains tumour progression via its dependence receptor activity.

APC DCC

2.24e-052165222158121
Pubmed

Neuroligin-1 induces neurite outgrowth through interaction with neurexin-1β and activation of fibroblast growth factor receptor-1.

NLGN1 NRXN1

2.24e-052165222750515
Pubmed

Myc heterozygosity attenuates the phenotypes of APC deficiency in the small intestine.

MYC APC

2.24e-052165220140021
Pubmed

Structural and affinity studies of IgM polyreactive natural autoantibodies.

IGKV2D-28 IGKV2-28

2.24e-05216528993018
Pubmed

Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells.

FLNA SSTR5

2.24e-052165233428965
Pubmed

V genes of oxazolone antibodies in 10 strains of mice.

IGKV2D-28 IGKV2-28

2.24e-05216521936125
Pubmed

Role of c-Myc haploinsufficiency in the maintenance of HSCs in mice.

MYC APC

2.24e-052165233538795
Pubmed

The myc 3' wnt-responsive element suppresses colonic tumorigenesis.

MYC APC

2.24e-052165224567369
Pubmed

Upregulation of a functional form of the beta4 integrin subunit in colorectal cancers correlates with c-Myc expression.

MYC ITGB4

2.24e-052165216007143
Pubmed

Silencing of neuroligin function by postsynaptic neurexins.

NLGN1 NRXN1

2.24e-052165217360903
Pubmed

Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16.

IGKV2D-28 IGKV2-28

2.24e-05216522110659
Pubmed

DNA pooling: a comprehensive, multi-stage association analysis of ACSL6 and SIRT5 polymorphisms in schizophrenia.

ACSL6 SIRT5

2.24e-052165216827919
Pubmed

β(IV)-Spectrin regulates TREK-1 membrane targeting in the heart.

SPTBN4 KCNK2

2.24e-052165224445605
Pubmed

Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors.

MYC APC

2.24e-052165223118011
Pubmed

The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export.

BCLAF1 THRAP3

2.24e-052165229112714
Pubmed

Expression of neurexin and neuroligin in the enteric nervous system and their down-regulated expression levels in Hirschsprung disease.

NLGN1 NRXN1

2.24e-052165223264101
Pubmed

GSK3 controls axon growth via CLASP-mediated regulation of growth cone microtubules.

CLASP1 GSK3A

2.24e-052165221937714
Pubmed

[Expressions of APC and c-Myc and its implication on non-small cell lung cancer].

MYC APC

2.24e-052165221302450
Pubmed

Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse.

MYC APC

2.24e-052165217106247
Pubmed

Abundance and Significance of Neuroligin-1 and Neurexin II in the Enteric Nervous System of Embryonic Rats.

NLGN1 NRXN1

2.24e-052165228194405
Pubmed

Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer.

MYC VWA2

2.24e-052165230038405
Pubmed

Structural basis for synaptic adhesion mediated by neuroligin-neurexin interactions.

NLGN1 NRXN1

2.24e-052165218084303
Pubmed

Modulation of elastase binding to elastin by human alveolar macrophage-derived lipids.

ELANE ELN

2.24e-052165210471600
Pubmed

C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine.

MYC APC

2.24e-052165218593890
Pubmed

Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms.

IGKV2D-28 IGKV2-28

2.24e-05216522263605
Pubmed

IgM binding to injured tissue precedes complement activation during skeletal muscle ischemia-reperfusion.

IGKV2D-28 IGKV2-28

2.24e-052165215522311
Pubmed

Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.

MYC APC

2.24e-052165218171987
Pubmed

Neurexin-neuroligin cell adhesion complexes contribute to synaptotropic dendritogenesis via growth stabilization mechanisms in vivo.

NLGN1 NRXN1

2.24e-052165220869594
Pubmed

Neuroligin 1: a splice site-specific ligand for beta-neurexins.

NLGN1 NRXN1

2.24e-05216527736595
Pubmed

ELL targets c-Myc for proteasomal degradation and suppresses tumour growth.

MYC ELL

2.24e-052165227009366
Pubmed

SIRT5 promote malignant advancement of chordoma by regulating the desuccinylation of c-myc.

MYC SIRT5

2.24e-052165238532359
Pubmed

Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism.

NLGN1 NRXN1

2.24e-052165215797875
Pubmed

A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins.

NLGN1 NRXN1

2.24e-052165216242404
Pubmed

Early induced IgM as a predictor and risk factor for severe disease outcome after West Nile virus infection.

IGKV2D-28 IGKV2-28

2.24e-052165215219549
Pubmed

Myc deletion rescues Apc deficiency in the small intestine.

MYC APC

2.24e-052165217377531
Pubmed

Amino acid sequence of the light chain variable region from a mouse anti-digoxin hybridoma antibody.

IGKV2D-28 IGKV2-28

2.24e-05216526404298
Pubmed

Neurexin mediates the assembly of presynaptic terminals.

NLGN1 NRXN1

2.24e-052165212796785
Pubmed

Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex.

NLGN1 NRXN1

2.24e-052165216846852
Pubmed

Mediation of the DCC apoptotic signal by DIP13 alpha.

DCC APPL1

2.24e-052165212011067
Pubmed

Btf and TRAP150 have distinct roles in regulating subcellular mRNA distribution.

BCLAF1 THRAP3

2.24e-052165223778535
Pubmed

A critical role for the regulated wnt-myc pathway in naive T cell survival.

MYC APC

2.24e-052165225429066
Pubmed

RIPK3-Induced Inflammation by I-MDSCs Promotes Intestinal Tumors.

RIPK3 APC

2.24e-052165230786994
Pubmed

Neurexin and Neuroligin-based adhesion complexes drive axonal arborisation growth independent of synaptic activity.

NLGN1 NRXN1

2.24e-052165229504935
Pubmed

Characterization of the interaction of a recombinant soluble neuroligin-1 with neurexin-1beta.

NLGN1 NRXN1

2.24e-052165214522992
Pubmed

Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation.

TCF3 APC

2.24e-052165223658527
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

BDP1 SETD1B CLASP1 NDE1 DNAJA2 ANKRD26 APC GSK3A LUZP1 MCM3AP PPIL2 CLSPN

2.64e-055881651238580884
Pubmed

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.

FLNA CLASP1 NDE1 BCLAF1 IRS1 GSK3A CLK3 THRAP3

3.19e-05255165815324660
Pubmed

Beta-catenin is temporally regulated during normal liver development.

MYC APC GSK3A

3.67e-0514165315057752
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

MYC CRTC3 TCF3 SCHIP1 EPS8L2 RAP1GAP CLASP1 NDE1 CPSF6 BCLAF1 TYSND1 MAP3K1 MCM3AP EIF4G2 CLSPN THRAP3

3.79e-0510381651626673895
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

SHANK1 ATRN EGLN2 RAP1GAP DNAJA2 APC ADAMTS8 FTCD ARMCX4 GSK3A SPTBN4 SARS2 YLPM1 EIF4G2 APPL1 RAB11FIP4 WDFY3 DNAJB2

4.25e-0512851651835914814
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

FLNA TUT4 BCLAF1 DNAJA2 ANKRD26 APC TNRC6B SRPRB LUZP1 YLPM1 PPIL2 THRAP3 AHNAK2

4.55e-057241651336232890
Pubmed

Exploration of human ORFeome: high-throughput preparation of ORF clones and efficient characterization of their protein products.

NKX2-6 MYO15B PTPRN2

4.58e-0515165318316326
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

SHANK1 ACSL6 FLNA MYH11 RAP1GAP CLASP1 BCLAF1 DNAJA2 APC GRIN1 ARHGEF17 LUZP1 SPTBN4 PDIA6 SAFB EIF4G2 BRSK1 THRAP3 WNK2

5.29e-0514311651937142655
Pubmed

A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.

FLNA MYH11 USH1C MYO15B

6.25e-0545165422114352
Pubmed

MEK kinase 1 interacts with focal adhesion kinase and regulates insulin receptor substrate-1 expression.

IRS1 MAP3K1

6.69e-053165212458213
Pubmed

betaIV spectrin, a new spectrin localized at axon initial segments and nodes of ranvier in the central and peripheral nervous system.

SPTBN4 PTPRN2

6.69e-053165211086001
Pubmed

Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism.

MYC CLK3

6.69e-053165232453420
Pubmed

Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization.

MYC GSK3A

6.69e-053165214563837
Pubmed

Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals.

NLGN1 NRXN1

6.69e-053165234320240
Pubmed

Identification of MYC as an antinecroptotic protein that stifles RIPK1-RIPK3 complex formation.

MYC RIPK3

6.69e-053165232753382
Pubmed

TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression.

APC IRS1

6.69e-053165230679431
Pubmed

The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.

MYC APC

6.69e-053165223217706
Pubmed

Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice.

RAP1GAP APC

6.69e-05316528978063
Pubmed

Integrin alpha6Bbeta4 inhibits colon cancer cell proliferation and c-Myc activity.

MYC ITGB4

6.69e-053165219586553
Pubmed

Phosphorylation of Ser357 of rat insulin receptor substrate-1 mediates adverse effects of protein kinase C-delta on insulin action in skeletal muscle cells.

IRS1 GSK3A

6.69e-053165218285345
Pubmed

Copy number of the Adenomatous Polyposis Coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene.

APC DCC

6.69e-053165226970738
Pubmed

Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells.

MYC TCF3

6.69e-053165229339775
Pubmed

Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells.

MYC DLX4

6.69e-053165218026954
Pubmed

Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss.

MYC APC

6.69e-053165220736363
Pubmed

Exophilin-5 regulates allergic airway inflammation by controlling IL-33-mediated Th2 responses.

EXPH5 RAB27A

6.69e-053165232240120
Pubmed

Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo.

MYC APC

6.69e-053165222884366
Pubmed

Constitutive GDP/GTP exchange and secretion-dependent GTP hydrolysis activity for Rab27 in platelets.

EXPH5 RAB27A

6.69e-053165216880209
Pubmed

A stromal cell-derived membrane protein that supports hematopoietic stem cells.

IRS1 SNED1

6.69e-053165212665856
Pubmed

Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.

NLGN1 NRXN1

6.69e-053165217582332
Pubmed

Recognition of immunoglobulins by Fcgamma receptors.

IGLV5-37 IGLV4-69 IGLV2-23 IGKV3-20

8.08e-0548165411955599
Pubmed

Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease.

FLNA ITGB4 SPTBN4

8.12e-0518165312119179
Pubmed

Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells.

BCLAF1 THRAP3 ELL

8.12e-0518165320064376
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

MYC TUT4 CLASP1 EXPH5 USP24 DIDO1 IRS1 AHDC1 WDFY3 KAT6B MN1 VPS13B

4.23e-0730016312M8702
CoexpressionMARTENS_TRETINOIN_RESPONSE_UP

SEMA6C EPS8L2 RIPK3 COL20A1 KRT85 NKX2-6 GRIN1 ADAMTS8 PLXNB2 HMCN2 KCNA6 PLCH2 AIFM3 PPIL2 CACNA1I TMEM151A MN1 WNK2 OPLAH

1.68e-0685516319M2098
CoexpressionDAZARD_UV_RESPONSE_CLUSTER_G6

TUT4 CLASP1 EXPH5 USP24 IRS1 KAT6B MN1 VPS13B

3.64e-061451638M1810
CoexpressionAtlasfacebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4

SHANK1 MYC STARD13 CBLN3 RIPK3 SPEG NLGN1 SNED1 BMP1 LRIG3 ARSA KCNA6 NRXN1 ELN TMEM151A CHST2 CCL21 KAT6B MN1 DCAF4 PDZRN3 OPLAH CCDC102A

1.73e-05114816023facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4
CoexpressionAtlasAravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2

USH1C IGLV2-23 KRT20 IGKV2D-28 DMBT1 IGKV3-20 IGKV2-28

4.82e-051261607Arv_SC-HD_500_K2
CoexpressionAtlasfacebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2

SHANK1 MYC BORCS6 SEMA6C SAMD1 FLNA CRTC3 RAP1GAP RIPK3 PLXNB2 SNED1 BMP1 LRIG3 KCNA6 NRXN1 ELN RAB11FIP4 CCL21 KAT6B MN1 PDZRN3 OPLAH CCDC102A

4.94e-05122816023facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2
CoexpressionAtlasAravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5

USH1C IGLV4-69 IGLV2-23 KRT20 IGKV2D-28 DMBT1 IGKV3-20 IGKV2-28

7.64e-051831608Arv_SC_fibroblast_1000_K5
ToppCellnormal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass

SRPRB IGLV5-37 IGLV4-69 IGLV2-23 PDIA6 ARSA IGKV2D-28 FCRL5 BRSK1 IGKV3-20 IGKV2-28

8.46e-1118116511949ac3b60e7fb5968da4c4e872965fb4e10f4a35
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DCC SRPRB IGLV4-69 PDIA6 ARSA IGKV2D-28 FCRL5 CHST2 IGKV3-20

1.46e-0816916590c2384f780ec25710ebb35c0b0df8f4afb53c9b1
ToppCelltumor_Lung-B_lymphocytes-MALT_B_cells|tumor_Lung / Location, Cell class and cell subclass

DCC SRPRB PDIA6 ARSA IGKV2D-28 FCRL5 CHST2 BRSK1 IGKV3-20

2.18e-08177165937e03f51925345f5f716ef3abe1d2c4ccf129020
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue

DCC IGLV2-23 PDIA6 ARSA IGKV2D-28 FCRL5 BRSK1 IGKV3-20 IGKV2-28

2.90e-081831659a6866951866373a1029e04818f4a4a31278c409d
ToppCellPCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

TMPRSS9 SCHIP1 COL20A1 NLGN1 ADAM12 NRXN1 KCNK2 INSM2 ECEL1

3.19e-081851659a8946379fc066903fe8f4bc9cbf693b7b424a0cd
ToppCellMesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor

FLNA MYH11 SPEG IRS1 ADAMTS8 SMTN DACH2 ELN PDZRN3

4.01e-081901659645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCellBronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DCC IGLV5-37 IGLV2-23 IGKV3D-7 IGKV2D-28 FCRL5 BRSK1 IGKV3-20 IGKV2-28

5.01e-08195165913f4ee21568fd747608412d33559d10561dbb3c8
ToppCell11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class

FLNA MYH11 SPEG IRS1 ADAMTS8 SMTN DACH2 ELN PDZRN3

5.24e-08196165905530fe7a5681c2f39b95016cd22ef99d6ac0430
ToppCelldroplet-Heart-HEART-1m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH11 SPEG IRS1 ARHGEF17 GDF10 BMP1 C11orf96 ELN CHST2

5.24e-0819616591eb14182ef26e6141f510d397b00bf8a12efda3e
ToppCell18-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class

FLNA MYH11 SPEG IRS1 ADAMTS8 SMTN DACH2 ELN PDZRN3

5.97e-0819916599dd130c041beaa319727f9d22b3f45ba0da49487
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

MYH11 SPEG IRS1 ADAMTS8 SMTN DACH2 ELN PDZRN3

3.32e-071771658b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FLNA MYH11 SPEG IRS1 SMTN DACH2 ELN PDZRN3

3.94e-07181165825915e2500430a902db37d79a749ce2990b69810
ToppCelldroplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH11 COL6A5 ARHGEF17 GDF10 GPR162 NRXN1 C11orf96 CHST2

4.10e-071821658c84f44391932080df31c8765e363c3dff64b2bd1
ToppCellmetastatic_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass

SRPRB IGLV2-23 PDIA6 ARSA AIFM3 IGKV2D-28 BRSK1 IGKV3-20

4.10e-07182165827d1688fdfc570cedd233aa7030bce7d9b604d42
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B_plasma|lymph-node_spleen / Manually curated celltypes from each tissue

DCC PDIA6 ARSA IGKV2D-28 FCRL5 BRSK1 IGKV3-20 IGKV2-28

4.28e-071831658beadc69f511cf183e493cb445135f0748ab8b20e
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLNA MYH11 SPEG IRS1 DCC SYT10 ELN PDZRN3

4.84e-0718616586add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCellhealthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass

TCF3 IGLV2-23 PDIA6 IGKV3D-7 IGKV2D-28 FCRL5 IGKV3-20 IGKV2-28

4.84e-071861658e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FLNA MYH11 SPEG IRS1 ADAMTS8 SMTN DACH2 ELN

5.25e-0718816584d1e5f85342ae550086609d7680e32730b78b5d2
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

FLNA MYH11 SPEG IRS1 ADAMTS8 SMTN DACH2 AHNAK2

5.46e-071891658b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FLNA MYH11 SPEG ADAMTS8 SMTN DACH2 ELN AHNAK2

5.46e-071891658da9ecc0d7b81c1901f30f97bb44112dc85444a66
ToppCellwk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

STARD13 TMPRSS9 SCHIP1 COL20A1 ADAM12 NRXN1 KCNK2 ECEL1

5.69e-0719016584a777d8aa19cadd3b61b023772df142421a89113
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA MYH11 SPEG ADAMTS8 ARHGEF17 SMTN C11orf96 WNK2

5.92e-0719116588e8beb8e8a3b33cac83d3f7ce915a71e3654fdab
ToppCell18-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class

FLNA MYH11 IRS1 ADAMTS8 SMTN SNED1 DACH2 C11orf96

5.92e-07191165886ce98d2c90c196474b06869de888cf5d1eed196
ToppCellnormal_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass

SRPRB IGLV2-23 PDIA6 ARSA IGKV2D-28 FCRL5 IGKV3-20 IGKV2-28

6.15e-071921658119832d4aee29ddda2485fc3e5dcdaacf833cc30
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IGLV5-37 IGLV4-69 IGLV2-23 IGKV3D-7 IGKV2D-28 FCRL5 IGKV3-20 IGKV2-28

6.40e-07193165834f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH11 COL20A1 SPEG ADAMTS8 SYT10 SMTN ELN PDZRN3

6.66e-07194165891205b22650e7ecdb72bb59348ce2530b76c532c
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH11 COL20A1 SPEG ADAMTS8 SYT10 SMTN ELN PDZRN3

6.66e-0719416586e12a7da35be4c0ecf998ef94b8989b89d74b200
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH11 COL20A1 SPEG ADAMTS8 SYT10 SMTN ELN PDZRN3

6.66e-071941658c52f10140c66e8c0566421c3d535d5d92bf595e1
ToppCell15-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class

FLNA MYH11 SPEG IRS1 SMTN DACH2 ELN PDZRN3

7.19e-0719616580e45817625b96d21a8cc4dfbbd465ee6403b6802
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLNA MYH11 SPEG ADAMTS8 SMTN C11orf96 MN1 PDZRN3

7.47e-071971658ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCellTracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FLNA MYH11 SPEG ADAMTS8 ARHGEF17 SMTN C11orf96 CCL21

8.06e-0719916580a145172787f40d0fdaf21188d539ffaf7ece3e4
ToppCell11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class

FLNA MYH11 SPEG IRS1 ADAMTS8 SMTN DACH2 ELN

8.06e-0719916581a8c77d241bd817a195e1532fd25f51358cb1ff1
ToppCellControl_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type

FLNA MYH11 IRS1 GDF10 SYT10 SMTN ELN PDZRN3

8.37e-072001658c5e051f1aac8dda376c342a9932785a23450e073
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLNA MYH11 SPEG SMTN HMCN2 C11orf96 ELN PDZRN3

8.37e-072001658a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCellControl_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

FLNA MYH11 IRS1 GDF10 SYT10 SMTN ELN PDZRN3

8.37e-0720016589d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SHROOM3 EXPH5 BMP1 KCNK2 KRT20 CACNA1I PDZRN3

2.02e-0615716575aee90ad7aaa65fdabc23597451da5e48db8f4e6
ToppCell368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

MYH11 ADAMTS8 GDF10 SMTN SNED1 HMCN2 SAMD14

2.81e-0616516573d2acdae0dd2b79a15f74158e8e566ce22b4218e
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MYC SEMA6C CBLN3 ADAM12 GSK3A SARS2 KCNK2

2.92e-061661657c11dcf9705b85ac3da6ae86358f5ffd64ae8327e
ToppCellChildren_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor

SRRM4 USH1C SPTBN4 NRXN1 DACH2 PTPRN2 WNK2

3.29e-061691657b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell(09)_Ionocytes-(3)_72hpi|(09)_Ionocytes / shred by cell type and Timepoint

FLNA TCF3 WASHC1 USP24 VWA2 MN1

3.47e-061101656fce7d5a0617fc664b657f5bb9abb290e7cc234cb
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLNA MYH11 SPEG ARHGEF17 C11orf96 ELN WNK2

4.14e-061751657d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FLNA MYH11 SPEG ADAMTS8 C11orf96 KRT20 ELN

4.14e-061751657316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLNA MYH11 SPEG ARHGEF17 C11orf96 ELN WNK2

4.14e-061751657454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FLNA MYH11 SPEG ADAMTS8 C11orf96 KRT20 ELN

4.14e-061751657a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCellControl-Stromal-SMC|Control / Disease state, Lineage and Cell class

MYH11 SPEG ADAMTS8 ARHGEF17 SMTN ELN PDZRN3

4.80e-0617916571378051bc62009eec2dbecf3d5d89baedbeb84eb
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

FLNA MYH11 SPEG NLGN1 SMTN ELN PDZRN3

4.98e-061801657d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMPRSS9 COL6A5 DCC SNED1 ELANE ELN PDZRN3

5.16e-0618116579e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SRPRB IGLV4-69 IGLV2-23 IGKV3D-7 FCRL5 BRSK1 IGKV3-20

5.16e-061811657e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FLNA MYH11 IRS1 SMTN DACH2 ELN PDZRN3

5.16e-061811657d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TCF3 EPS8L2 IRS1 NKX2-6 GRIN1 ADAM12 VWA2

5.55e-061831657bc24145855bf4d027a8058bf92bc796c10f241bb
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TCF3 EPS8L2 IRS1 NKX2-6 GRIN1 ADAM12 VWA2

5.55e-0618316574c325ee6da070513097a11445ec95b0415ffd8a2
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV4-69 IGLV2-23 PDIA6 IGKV2D-28 FCRL5 BRSK1 IGKV3-20

5.75e-06184165715f2c10101ccc8ed059520fc082ee42593dff269
ToppCellControl-Stromal-SMC|World / Disease state, Lineage and Cell class

MYH11 SPEG ADAMTS8 ARHGEF17 SMTN ELN PDZRN3

5.75e-06184165788b1a4c9a96a99fc3a39f7a2c3d0838739606f3e
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV4-69 IGLV2-23 PDIA6 IGKV2D-28 FCRL5 BRSK1 IGKV3-20

5.75e-061841657a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCelldroplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAP1GAP COL20A1 KRT85 ADAM12 KCNA6 NRXN1 ECEL1

5.75e-061841657a7399a72f065d68800e3e0b2031d9894e0cc0ba4
ToppCelldroplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH11 ADAMTS8 ARHGEF17 GDF10 NRXN1 PLCH2 C11orf96

5.75e-061841657f4344f3c407b2d4d703fe56e43d84dbfe60ba833
ToppCellILEUM-non-inflamed-(5)_IgA_plasma_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SRPRB IGLV2-23 PDIA6 ARSA FCRL5 BRSK1 IGKV3-20

5.96e-061851657a44e418a75fd54fd8ba266a93c0e9e3ac2e6e315
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYH11 SPEG IRS1 DCC SYT10 ELN PDZRN3

5.96e-061851657e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MYH11 SPEG IRS1 ADAMTS8 SNED1 DACH2 C11orf96

5.96e-061851657e58a009aaf342be019a909747b1895d5987d4daf
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV4-69 IGLV2-23 PDIA6 IGKV2D-28 FCRL5 IGKV3-20 IGKV2-28

5.96e-06185165708bc817908076734d66f2805cb954141f2cc5a18
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV4-69 IGLV2-23 PDIA6 IGKV2D-28 FCRL5 IGKV3-20 IGKV2-28

5.96e-0618516571704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMPRSS9 SRRM4 SSTR5 SYT10 NRXN1 DACH2 PDZRN3

6.17e-0618616572fab7abed16a894afdd0207e86fc43a25a77fb9e
ToppCell5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMPRSS9 SRRM4 SSTR5 SYT10 NRXN1 DACH2 PDZRN3

6.17e-061861657ea2c8e0df038a00062d2098b4a9ac85141b9a728
ToppCell5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMPRSS9 SRRM4 SSTR5 SYT10 NRXN1 DACH2 PDZRN3

6.17e-061861657714765585a644bf9817ab6eb3001b43b3c2d2410
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

SPTLC3 MYH11 SPEG IRS1 ADAMTS8 DACH2 ELN

6.40e-061871657387cb27c8a20031cd87381a9e1172f1f62e1488b
ToppCellILEUM-non-inflamed-(5)_Plasma|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SRPRB IGLV2-23 PDIA6 ARSA FCRL5 BRSK1 IGKV3-20

6.40e-061871657c85f300c76043cc10935478591c9322b78845264
ToppCelldroplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAP1GAP COL20A1 KRT85 ADAM12 KCNA6 NRXN1 ECEL1

6.62e-0618816578385fd384fc55e3b17802bb6698eb93b2c16d7f2
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FLNA MYH11 SPEG ARHGEF17 C11orf96 ELN WNK2

6.62e-061881657b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYH11 SPEG IRS1 DCC SYT10 ELN PDZRN3

6.62e-061881657293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FLNA MYH11 SPEG IRS1 HMCN2 DACH2 ELN

6.62e-061881657c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV5-37 IGLV2-23 PDIA6 IGKV2D-28 FCRL5 IGKV3-20 IGKV2-28

6.62e-0618816576844cebca177fdf38b21a40d606230a033717a3a
ToppCelldroplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAP1GAP COL20A1 KRT85 ADAM12 KCNA6 NRXN1 ECEL1

6.62e-061881657cb9d0b48e2fd9cc576132803273b9c0382900944
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FLNA MYH11 SPEG ARHGEF17 C11orf96 ELN WNK2

6.86e-061891657127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FLNA MYH11 SPEG ARHGEF17 C11orf96 ELN WNK2

6.86e-0618916572cfb4d12f75678d1619f4743838a0e954bd57761
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CBLN3 EXPH5 GRIN1 ADAM12 GPR162 SPTBN4 SAMD14

6.86e-061891657f57200c93d39c9bce1adba0a6a1c178c028dd86b
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

SPTLC3 FLNA MYH11 SPEG IRS1 ADAMTS8 DACH2

6.86e-0618916570abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLNA MYH11 SPEG DCC SMTN ELN PDZRN3

7.10e-061901657562ee3b025c29edf07b8b344323edb49d82f1c7e
ToppCellILEUM-inflamed-(5)_IgG_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SRPRB IGLV2-23 PDIA6 ARSA FCRL5 BRSK1 IGKV3-20

7.10e-06190165776baa41b217ae6fd62a58971912e8ecfe1dc03e7
ToppCellnormal_Lymph_Node-B_lymphocytes-MALT_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass

DCC IGLV4-69 PDIA6 ARSA FCRL5 BRSK1 IGKV3-20

7.10e-0619016571f907016980ccfbf089e354d91d931771e8a83e0
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLNA MYH11 SPEG DCC SMTN ELN PDZRN3

7.10e-061901657f5fb989afabb49d64d91324570cd8c80a4b9e67d
ToppCell3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNA MYH11 IRS1 NLGN1 SYT10 SMTN ELANE

7.10e-061901657591310e615700321a010a4b90405cbbbbdb3aade
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL6A5 ADAMTS8 DCC GDF10 SNED1 ELN PDZRN3

7.34e-061911657b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYH11 SPEG IRS1 DCC SMTN ELN PDZRN3

7.34e-06191165708042952431ca1a6fd7dfc13f36eb28643979598
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYH11 SPEG IRS1 ARHGEF17 SYT10 ELN PDZRN3

7.34e-0619116577853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA MYH11 SPEG ADAMTS8 SMTN C11orf96 WNK2

7.34e-06191165760bc1f3efa7bbad5cb7944fe5e049ea79cd1745a
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLNA MYH11 SPEG IRS1 SYT10 ELN PDZRN3

7.60e-061921657992d08092edbc68c47b945deb8708379738c239a
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 SPEG ADAMTS8 GDF10 SMTN C11orf96 ELN

7.60e-06192165793903576dddd8227328e4ced75aa7625eedb9baf
ToppCell5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SCHIP1 CLASP1 COL20A1 SRRM4 NRXN1 KCNK2 PDZRN3

7.60e-06192165756f2388c9c4e19883ae5cff332c77f596ff744a8
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA MYH11 SPEG SMTN C11orf96 ELN MN1

7.86e-06193165718e11d515147accef9aee26e934b358b445e18e2
ToppCellfacs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

THSD1 GDF10 MAP3K1 KCNK2 VWA2 MN1 PDZRN3

7.86e-061931657eba3c70701b051bc1ed1f4db9270cb27a77ffc3e
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

ATRN BCLAF1 CPD APPL1 ASXL2 WDFY3 VPS13B

7.86e-061931657abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 SPEG ADAMTS8 GDF10 SMTN C11orf96 ELN

7.86e-061931657cfab88935abe0a15632c5eec8ff00a857ec9b3ed
ToppCellwk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

SPTLC3 FLNA MYH11 IRS1 SNED1 DACH2 PDZRN3

7.86e-0619316572f203f6f0c2135acb046c9351a633c3b5b254a46
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA MYH11 SPEG SMTN C11orf96 ELN MN1

7.86e-0619316577766f495f2f945802ef9a5b994cd00bb64d0dfe3
ToppCellTracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DCC IGLV2-23 IGKV3D-7 IGKV2D-28 FCRL5 IGKV3-20 IGKV2-28

7.86e-061931657282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA MYH11 SPEG SMTN C11orf96 ELN MN1

7.86e-061931657ce3e8cf30b7b4d5c7a8f3d64c21d81d2c3cab5c1
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL6A5 ADAMTS8 DCC GDF10 SNED1 ELN PDZRN3

8.13e-0619416576e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellfacs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

THSD1 GDF10 MAP3K1 KCNK2 VWA2 MN1 PDZRN3

8.13e-0619416575d30d3d41d5f19cdf3077cc609aa2738762cb8c5
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

NLGN1 SNED1 HMCN2 ELANE ELN MN1 PDZRN3

8.41e-061951657ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCellTracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DCC IGLV5-37 IGLV2-23 IGKV2D-28 FCRL5 BRSK1 IGKV2-28

8.41e-061951657df009b18898c10686f75cf72b4ec0eff18f5bb50
DrugTyloxapol [25301-02-4]; Up 200; 4uM; HL60; HT_HG-U133A

KRT85 APC SSTR5 ITGB4 AHDC1 GSK3A KCND1 MCM3AP TTLL1 DLX4 DCAF4 ELL

1.48e-08197159123074_UP
DrugChlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A

APC THSD1 SSTR5 ARHGEF17 GSK3A SNED1 PTPRN2 PLCH2 EIF4G2 CHST2 VPS13B

1.46e-07197159112279_UP
DrugW-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A

FLNA TCF3 ITGB4 GSK3A BMP1 PPIL2 CACNA1I ALDH4A1 ELL

9.31e-061941599440_UP
DrugTrichlorfon [52-68-6]; Up 200; 15.6uM; MCF7; HT_HG-U133A

PDE4A SETD1B THSD1 ARHGEF17 CEP68 PPIL2 MINDY1 ELL AHNAK2

1.05e-0519715991675_UP
Drugtroglitazone; Up 200; 10uM; HL60; HT_HG-U133A

EPS8L2 NDE1 IRS1 SNED1 SLC22A18AS PTPRN2 PPIL2 CACNA1I AHNAK2

1.14e-0519915996191_UP
DrugEsculin Hydrate [531-75-9]; Up 200; 11.8uM; HL60; HT_HG-U133A

TCF3 SMTN BMP1 NRXN1 PTPRN2 CACNA1I ELN DDX4 ELL

1.14e-0519915993052_UP
DrugHydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A

NDE1 EXPH5 SIRT5 CES2 BMP1 SLC22A18AS PPIL2 DLX4 DMBT1

1.19e-0520015995494_UP
DrugAminophylline [317-34-0]; Down 200; 9.6uM; HL60; HT_HG-U133A

EXPH5 APC NLGN1 ITGB4 CEP68 MCM3AP YLPM1 KRT20 WDFY3

1.19e-0520015993036_DN
DrugMethyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; HL60; HT_HG-U133A

BORCS6 STARD13 APC GSK3A BMP1 MCM3AP PPIL2 ALDH4A1 ELL

1.19e-0520015992190_UP
DrugAndrogen Antagonists

SHANK1 GRIN1 NLGN1 DCC NRXN1 CACNA1I

1.43e-05751596ctd:D000726
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

MYC SETD1B DIDO1 IRS1 SAFB PPIL2 WDFY3 KAT6B

3.15e-0517415985945_DN
DrugIndium

SSTR5 SNED1 YLPM1 CCL21 KAT6B

5.76e-05591595CID000105148
Drug2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A

SPEG APC ARHGEF17 SIRT5 GSK3A PPIL2 WDFY3 VPS13B

6.33e-0519215983400_DN
Drug2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A

PDE4A ANKRD26 APC ARHGEF17 LUZP1 RAB27A MINDY1 AHNAK2

6.33e-0519215981634_UP
Druggeldanamycin; Down 200; 1uM; PC3; HT_HG-U133A

SETD1B CPSF6 SPEG TNRC6B AHDC1 LUZP1 SMTN DCAF4

6.56e-0519315981228_DN
DrugCarbachol [51-83-2]; Down 200; 21.8uM; MCF7; HT_HG-U133A

ATRN NDE1 CPD PLXNB2 CES2 SMTN CEP68 ALDH4A1

6.80e-0519415985342_DN
DrugOmeprazole [73590-58-6]; Down 200; 11.6uM; HL60; HT_HG-U133A

EXPH5 IRS1 GSK3A BMP1 SAFB PTPRN2 WDFY3 DNAJB2

6.80e-0519415982467_DN
DrugSulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A

APC ITGB4 MAP3K1 SMTN CEP68 MCM3AP DDX43 RAB27A

7.05e-0519515986799_DN
DrugMethazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A

EXPH5 ARHGEF17 ITGB4 LUZP1 SMTN MYO1F PPIL2 TTLL1

7.05e-0519515986268_UP
Drug15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A

STARD13 TCF3 ANKRD26 THSD1 MAP3K1 CEP68 PPIL2 CACNA1I

7.05e-0519515985228_DN
DrugFelbinac [5728-52-9]; Down 200; 18.8uM; MCF7; HT_HG-U133A

ATRN TNRC6B LUZP1 SAFB PPIL2 ALDH4A1 WDFY3 ELL

7.31e-0519615985700_DN
DrugHydroflumethiazide [135-09-1]; Up 200; 12uM; MCF7; HT_HG-U133A

NDE1 TNRC6B ITGB4 CEP68 MCM3AP MYO1F TTLL1 AHNAK2

7.31e-0519615981687_UP
DrugTheobromine [83-67-0]; Up 200; 22.2uM; MCF7; HT_HG-U133A

BORCS6 APC ADAM12 GSK3A BMP1 PLCH2 EIF4G2 DMBT1

7.31e-0519615984958_UP
DrugCiprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A

STARD13 ATRN NDE1 CES2 SAFB PPIL2 DNAJB2 RAB27A

7.58e-0519715986218_DN
DrugMeticrane [1084-65-7]; Down 200; 14.6uM; PC3; HT_HG-U133A

TCF3 CPD ADAM12 AHDC1 SIRT5 CES2 YLPM1 VPS13B

7.58e-0519715987282_DN
DrugDoxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A

TCF3 APC THSD1 SIRT5 LUZP1 SLC22A18AS PPIL2 WDFY3

7.58e-0519715983363_DN
DrugVincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A

BORCS6 THSD1 SIRT5 GSK3A MCM3AP EIF4G2 PPIL2 ELL

7.58e-0519715983784_DN
Drugaspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A

THSD1 ITGB4 MAP3K1 LUZP1 SMTN MCM3AP YLPM1 PPIL2

7.58e-0519715985564_DN
DrugSulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A

TNRC6B SMTN EIF4G2 MYO1F PPIL2 WDFY3 KAT6B ELL

7.58e-0519715981695_UP
DrugCarbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A

SPTLC3 TCF3 ARHGEF17 SLC22A18AS PTPRN2 ELN DNAJB2 VPS13B

7.85e-0519815982623_UP
DrugTacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; MCF7; HT_HG-U133A

EGLN2 TCF3 APC CPD MYO1F PPIL2 TTLL1 ALDH4A1

7.85e-0519815982633_DN
DrugSisomicin sulfate [53179-09-2]; Up 200; 2.8uM; HL60; HT_HG-U133A

PDE4A GRIN1 NLGN1 GPR162 GSK3A PPIL2 CACNA1I ALDH4A1

7.85e-0519815982493_UP
DrugTriamterene [396-01-0]; Up 200; 15.8uM; HL60; HT_HG-U133A

STARD13 RAP1GAP APC SSTR5 SIRT5 TTLL1 ELN KAT6B

7.85e-0519815981861_UP
DrugPhenethicillin potassium salt [132-93-4]; Down 200; 10uM; HL60; HT_HG-U133A

SPTLC3 NDE1 APC ITGB4 BMP1 KRT20 CACNA1I ELL

7.85e-0519815982542_DN
DrugIsocarboxazid [59-63-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A

TCF3 THSD1 ITGB4 LUZP1 BMP1 KCND1 PPIL2 RAB27A

7.85e-0519815983424_UP
Drug(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; HL60; HT_HG-U133A

STARD13 EPS8L2 PDE4A APC SMTN BMP1 CACNA1I ELN

7.85e-0519815982197_UP
DrugMethapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A

SPTLC3 APC ARHGEF17 SLC22A18AS MYO1F CACNA1I ELN AHNAK2

8.13e-0519915984990_UP
DrugNitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A

BORCS6 APC TNRC6B KRT20 PPIL2 ELL VPS13B AHNAK2

8.13e-0519915982303_UP
DrugBiperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A

ATRN TCF3 TUT4 APC NLGN1 EIF4G2 ELN AHNAK2

8.13e-0519915985644_DN
DrugSulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A

BORCS6 SPTLC3 SNED1 CEP68 MYO1F CACNA1I ALDH4A1 MINDY1

8.13e-0519915986212_UP
DrugGelsemine [509-15-9]; Up 200; 12.4uM; HL60; HT_HG-U133A

BORCS6 NDE1 EXPH5 GSK3A CEP68 BMP1 TTLL1 VPS13B

8.13e-0519915982162_UP
DrugCyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A

SSTR5 ARHGEF17 SMTN BMP1 PPIL2 CACNA1I DCAF4 AHNAK2

8.13e-0519915981521_UP
DrugHarmane hydrochloride [21655-84-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A

NDE1 APC TNRC6B BCKDHA THSD1 CES2 DNAJB2 ELL

8.13e-0519915982806_DN
DrugMepenzolate bromide [76-90-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A

SPTLC3 SPEG GRIN1 SIRT5 SNED1 BMP1 SLC22A18AS ELL

8.13e-0519915986024_UP
DrugMoxonidine [75438-57-2]; Up 200; 16.6uM; HL60; HT_HG-U133A

BORCS6 NDE1 GRIN1 SSTR5 SLC22A18AS PTPRN2 PPIL2 ELN

8.13e-0519915982923_UP
DrugEthosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A

STARD13 NDE1 CPSF6 USP24 BCKDHA AHDC1 CLK3 YLPM1

8.42e-0520015987308_DN
Drugbutylparaben

SHANK1 MYC GRIN1 NLGN1 DCC NRXN1 CACNA1I

1.20e-041571597ctd:C038091
DrugOl-ala-ala-pro-val

ELANE ELN

1.45e-0431592CID006443645
DrugCAAPV

ELANE ELN

1.45e-0431592CID005748391
DrugAC1Q6PLU

SARS2 APPL1

1.45e-0431592CID000119290
DrugACTM

ELN RAB27A

1.45e-0431592CID003082693
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

MYC SETD1B DIDO1 IRS1 PPIL2 WDFY3 KAT6B

2.12e-0417215975903_DN
DrugParthenolide [20554-84-1]; Down 200; 16.2uM; HL60; HG-U133A

MYC PDE4A USP24 PLXNB2 CEP68 MYO1F WDFY3

2.61e-0417815971736_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

MYC SETD1B USP24 DIDO1 IRS1 SAFB KAT6B

2.61e-041781597992_DN
DrugLinuron

MYC GRIN1 NLGN1 DCC NRXN1 CACNA1I

2.84e-041281596ctd:D008044
DrugAA 231-1

ELANE ELN

2.88e-0441592CID000125459
Drugparamethadione

DMRTA1 CACNA1I

2.88e-0441592CID000008280
DrugAC1NDXCO

ELANE ELN

2.88e-0441592CID004608426
DrugAC1L4UCL

ELANE ELN

2.88e-0441592CID000192449
DrugAC1MNK8M

ELANE ELN

2.88e-0441592CID003354088
DrugTEI-5624

ELANE ELN

2.88e-0441592CID000192291
Drugenzacamene

SHANK1 GRIN1 NLGN1 DCC NRXN1 CACNA1I

2.96e-041291596ctd:C038939
DrugHalcinonide [3093-35-4]; Up 200; 8.8uM; HL60; HT_HG-U133A

BORCS6 CPD GRIN1 PPIL2 CACNA1I ALDH4A1 DCAF4

3.19e-0418415972185_UP
DrugBisacodyl [603-50-9]; Down 200; 11uM; MCF7; HT_HG-U133A

STARD13 NDE1 ANKRD26 CES2 SMTN PDZRN3 RAB27A

3.75e-0418915975677_DN
DrugRolipram [61413-54-5]; Up 200; 14.6uM; HL60; HT_HG-U133A

STARD13 SPTLC3 NLGN1 ADAM12 KCND1 MCM3AP PPIL2

3.75e-0418915973072_UP
DrugDigoxigenin [1672-46-4]; Down 200; 10.2uM; PC3; HT_HG-U133A

SPTLC3 GSK3A CES2 CEP68 KRT20 PPIL2 DCAF4

3.87e-0419015974680_DN
DrugStrophantine octahydrate [11018-89-6]; Down 200; 5.4uM; PC3; HT_HG-U133A

APC CEP68 PTPRN2 WDFY3 MN1 DCAF4 RAB27A

3.87e-0419015976680_DN
Drug17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A

NDE1 DIDO1 LUZP1 YLPM1 WDFY3 DNAJB2 ELL

4.00e-0419115976933_UP
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA

MYC EPS8L2 CPSF6 CEP68 SAFB KAT6B RAB27A

4.00e-0419115971063_DN
DrugPindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A

TCF3 APC ADAM12 SIRT5 BMP1 MYO1F PPIL2

4.12e-0419215974496_DN
DrugAvermectin B1 [71751-41-2]; Up 200; 4.8uM; MCF7; HT_HG-U133A

MYC APC CPD SSTR5 GSK3A SLC22A18AS ALDH4A1

4.12e-0419215977218_UP
DrugKetotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A

NDE1 ARHGEF17 ITGB4 SLC22A18AS CAPRIN2 EIF4G2 CACNA1I

4.25e-0419315973200_DN
DrugTocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

BORCS6 NLGN1 USH1C LIPE MYO1F PPIL2 DLX4

4.39e-0419415974961_UP
DrugCarbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A

BORCS6 ARHGEF17 ITGB4 BMP1 NRXN1 CACNA1I DCAF4

4.39e-0419415974110_UP
DrugTocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A

TCF3 SPEG APC THSD1 ITGB4 CEP68 SAFB

4.39e-0419415974838_UP
DrugColchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A

FLNA NDE1 SPEG GSK3A SMTN BMP1 DMBT1

4.39e-0419415973213_UP
DrugAcetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A

TCF3 NDE1 AHDC1 CEP68 BMP1 YLPM1 ALDH4A1

4.39e-0419415971707_DN
Drug2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A

TCF3 ITGB4 GSK3A NRXN1 PPIL2 KAT6B DNAJB2

4.39e-041941597433_DN
DrugFludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A

THSD1 ARHGEF17 SIRT5 GSK3A SLC22A18AS PPIL2 AHNAK2

4.39e-0419415973977_DN
DrugFurazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A

TCF3 NLGN1 ITGB4 KCNK2 CACNA1I ELN DCAF4

4.39e-0419415974178_DN
Drug6-mercaptopurine monohydrate; Up 200; 100uM; MCF7; HG-U133A

BORCS6 SPEG DCC USH1C GSK3A LUZP1 CACNA1I

4.39e-041941597334_UP
Drugoctylmethoxycinnamate

SHANK1 GRIN1 NLGN1 DCC NRXN1 CACNA1I

4.41e-041391596ctd:C118580
DrugSalsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A

BORCS6 TUT4 THSD1 SMTN BMP1 ALDH4A1 DLX4

4.52e-0419515972791_DN
DrugThioperamide maleate [106243-16-7]; Down 200; 9.8uM; MCF7; HT_HG-U133A

SPEG THSD1 GSK3A ELN WDFY3 ELL VPS13B

4.52e-0419515973392_DN
DrugFamotidine [76824-35-6]; Up 200; 11.8uM; PC3; HG-U133A

ATRN SETD1B USP24 ADAM12 LUZP1 YLPM1 PPIL2

4.52e-0419515971946_UP
DrugCholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A

CPSF6 APC ADAM12 BMP1 PTPRN2 CACNA1I ELN

4.52e-0419515973298_UP
DrugDipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A

ARHGEF17 SLC22A18AS MYO1F KCNK2 CACNA1I DMBT1 AHNAK2

4.52e-0419515971517_UP
DrugPhenylpropanolamine hydrochloride [154-41-6]; Up 200; 21.4uM; MCF7; HT_HG-U133A

SPTLC3 TNRC6B SIRT5 GSK3A ARSA ELANE CHST2

4.52e-0419515973217_UP
DrugPentoxifylline [6493-05-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A

APC ARHGEF17 ADAM12 SLC22A18AS EIF4G2 CACNA1I ELL

4.52e-0419515972290_UP
Drugwortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A

TUT4 SETD1B NDE1 AHDC1 SIRT5 CEP68 WDFY3

4.52e-0419515971184_UP
DrugDorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; MCF7; HT_HG-U133A

APC SIRT5 LUZP1 SLC22A18AS PPIL2 RAB27A VPS13B

4.52e-0419515976259_UP
DrugMegestrol acetate [595-33-5]; Up 200; 10.4uM; HL60; HT_HG-U133A

STARD13 NLGN1 GSK3A PTPRN2 MCM3AP PPIL2 TTLL1

4.52e-0419515973091_UP
DrugNabumetone [42924-53-8]; Down 200; 17.6uM; HL60; HT_HG-U133A

TCF3 ANKRD26 APC GSK3A CES2 MCM3AP PPIL2

4.52e-0419515973108_DN
DrugFlecainide acetate [54143-56-5]; Up 200; 8.4uM; PC3; HT_HG-U133A

APC ITGB4 GSK3A MAP3K1 PTPRN2 MCM3AP PPIL2

4.52e-0419515974318_UP
DrugFluspirilen [1841-19-6]; Down 200; 8.4uM; MCF7; HT_HG-U133A

TCF3 ITGB4 SMTN YLPM1 PPIL2 WDFY3 PDZRN3

4.52e-0419515975008_DN
DrugMevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; MCF7; HT_HG-U133A

NDE1 GSK3A MAP3K1 CES2 EIF4G2 PPIL2 KAT6B

4.52e-0419515973459_DN
DrugLobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A

BORCS6 SPTLC3 TCF3 GSK3A CACNA1I ALDH4A1 DMBT1

4.52e-0419515972897_UP
DrugSecurinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A

ATRN TCF3 EXPH5 ANKRD26 GSK3A YLPM1 DNAJB2

4.52e-0419515973470_DN
DrugAcacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A

SPTLC3 PDE4A APC THSD1 AHDC1 YLPM1 PPIL2

4.52e-0419515974324_DN
DrugTrapidil [15421-84-8]; Down 200; 19.4uM; HL60; HT_HG-U133A

SPTLC3 ITGB4 AHDC1 MAP3K1 EIF4G2 PPIL2 ELL

4.66e-0419615973136_DN
Diseaseaortic measurement

TNRC6B ADAM12 SYT10 SMTN SPTBN4 ELN DCAF4 ELL

5.75e-052511558EFO_0020865
DiseaseAfrican Burkitt's lymphoma

MYC TCF3 FTCD

6.18e-05151553C0343640
DiseaseAlzheimer disease, Cognitive impairment

NKX2-6 BMP1 NRXN1

6.18e-05151553HP_0100543, MONDO_0004975
DiseaseBurkitt Leukemia

MYC TCF3 FTCD

6.18e-05151553C4721444
Diseaselevel of Sterol ester (27:1/20:3) in blood serum

MYH11 USP24 NRXN1

1.30e-04191553OBA_2045199
Diseaseautism spectrum disorder (implicated_via_orthology)

SHANK1 TMPRSS9 GRIN1 NLGN1 NRXN1 WDFY3

1.57e-041521556DOID:0060041 (implicated_via_orthology)
DiseaseEpidermolysis Bullosa

EXPH5 ITGB4

1.63e-0441552C0014527
Diseasecortical thickness

SHROOM3 CPSF6 TNRC6B ADAMTS8 USH1C GDF10 ADAM12 MAP3K1 LUZP1 YLPM1 KCNK2 DMRTA1 ELN RAB11FIP4 ELL WNK2

2.65e-04111315516EFO_0004840
DiseaseEpidermolysis Bullosa Simplex

EXPH5 ITGB4

2.71e-0451552C0079298
DiseaseNonsyndromic Deafness

BDP1 EPS8L2 USH1C MYO1F

8.90e-04811554C3711374
DiseaseBurkitt Lymphoma

MYC TCF3 FTCD

8.94e-04361553C0006413
Diseasepersonality trait

SPTLC3 NRXN1 DMRTA1

1.13e-03391553EFO_0004365
DiseaseUterine leiomyoma, estrogen-receptor negative breast cancer

EXPH5 TNRC6B

1.20e-03101552EFO_1000650, HP_0000131
DiseaseColorectal Carcinoma

SHANK1 MYC TCF3 APC DCC SMTN PTPRN2 MCM3AP KRT20 DMRTA1 VWA2

1.26e-0370215511C0009402
Diseaseinsulin sensitivity measurement, glucose homeostasis measurement

EXPH5 KRT28 IRS1

1.50e-03431553EFO_0004471, EFO_0006896
Diseaseresponse to angiotensin-converting enzyme inhibitor, Cough

CLASP1 ASXL2 VPS13B

1.83e-03461553EFO_0005325, HP_0012735
Diseasecortical surface area measurement

ACSL6 CBLN3 SHROOM3 CPSF6 APC TNRC6B GDF10 ADAM12 PLXNB2 MAP3K1 LUZP1 KCNK2 DMRTA1 RAB11FIP4 PDZRN3 WNK2

1.97e-03134515516EFO_0010736
DiseaseFEV/FEC ratio

STARD13 SPEG DCC ARHGEF17 ADAM12 MAP3K1 SMTN YLPM1 MYO1F HHIPL1 ELN DMBT1 CHST2 MN1 PDZRN3

2.11e-03122815515EFO_0004713
Diseasesusceptibility to childhood ear infection measurement

SEMA6C CDHR3 ADAM12 DACH2 VPS13B

2.14e-031711555EFO_0007904
DiseaseLeukemia, Myelocytic, Acute

MYC ACSL6 MYH11 ASXL2 MN1

2.25e-031731555C0023467
Diseasethyroid gland papillary carcinoma (is_marker_for)

MYC RAP1GAP

2.39e-03141552DOID:3969 (is_marker_for)
Diseaseschizophrenia, intelligence, self reported educational attainment

MYH11 NDE1 DCC PDIA6 NRXN1 PTPRN2 CACNA1I

2.43e-033461557EFO_0004337, EFO_0004784, MONDO_0005090
DiseaseFamilial thoracic aortic aneurysm and aortic dissection

FLNA MYH11 ELN

2.75e-03531553C4707243
Diseasechenodeoxycholate measurement

NKX2-6 DCC

2.75e-03151552EFO_0010471
Diseasepulse pressure measurement

SHROOM3 MYH11 TNRC6B ADAMTS8 GDF10 PLXNB2 SYT10 AHDC1 LUZP1 SPTBN4 CEP68 LRIG3 C11orf96 HHIPL1 ELN ELL

2.77e-03139215516EFO_0005763
Diseasebreast carcinoma

SHANK1 CLASP1 ANKRD26 TNRC6B NKX2-6 MAP3K1 PTPRN2 TTLL1 ASXL2 TMEM151A BRSK1 MN1 ELL

2.88e-03101915513EFO_0000305
Diseaseamino acid measurement

NLGN1 ADAM12 GPR162 HIBADH SYT10 PTPRN2 AIFM3 ELANE APPL1 WNK2

3.21e-0367815510EFO_0005134
DiseaseLipidemias

APC IRS1

3.54e-03171552C1706412
DiseaseHyperlipidemia

APC IRS1

3.54e-03171552C0020473
DiseaseAcute Myeloid Leukemia, M1

MYC MYH11 ASXL2 MN1

4.34e-031251554C0026998
DiseaseAcute Myeloid Leukemia (AML-M2)

MYC MYH11 ASXL2 MN1

4.34e-031251554C1879321
Diseaseurolithiasis

SHROOM3 HIBADH VPS13B

4.48e-03631553MONDO_0024647

Protein segments in the cluster

PeptideGeneStartEntry
ESGGVRGSLGSPGNR

USH1C

191

Q9Y6N9
VAFSSRLGGSRGAPG

DCAF4

466

Q8WV16
GVGARGSTASNPQRG

BDP1

16

A6H8Y1
RSFREVSGLQVGPGG

C1orf167

571

Q5SNV9
FGIPRTQGSDGGAQD

CCL21

16

O00585
VSGGSGVSQRPFRDR

ELL

196

P55199
LFGSRRPVLSGTGNG

DDX4

181

Q9NQI0
QPVFSGGDASGLGRR

CEP68

251

Q76N32
GIGAVPATGFLRQSG

AIFM3

426

Q96NN9
GLRGCFFSGTVNGEP

ADAMTS8

96

Q9UP79
QGCGGPRVGSADSRA

ANKRD60

46

Q9BZ19
TYVRRDTAGGGPGQA

CLK3

51

P49761
TGSIVGQQPFGGARA

ALDH4A1

511

P30038
GFGGSTDSGPIRQAD

ADAM12

691

O43184
SSGLRFGRGGFSEEV

SLC22A18AS

81

Q8N1D0
PVGGGGFRRANSEAS

AHDC1

1176

Q5TGY3
FARRQRSSAGGGGEP

ANKRD26

16

Q9UPS8
CSYVGRRGGGPQAIS

BMP1

186

P13497
ATSSGAGVPGGLFRA

DACH2

11

Q96NX9
GGQEGDFPGRTFSVS

DLX4

181

Q92988
GTSDQSGGGSKPRFE

ARMCX4

1306

Q5H9R4
EGQTARGGSPGSDRV

ASXL2

706

Q76L83
VVYRASGPDGATGRG

RAB27A

51

P51159
SGSLGFNIIGGRPSV

PDZRN3

256

Q9UPQ7
GVGNSGDSVRGGRSE

NKX2-6

111

A6NCS4
RNFVIQGGDPTGTGT

PPIL2

326

Q13356
GRGRSASSGLGEFNA

RAB11FIP4

521

Q86YS3
GIPDRFSGSSSGAER

IGLV4-69

81

A0A075B6H9
GVARGSPGRAALGES

PTPRN2

346

Q92932
GSMNAFTGRGSPGRG

KAT6B

361

Q8WYB5
GGSSGDRGSNPLDGR

ARHGEF17

491

Q96PE2
DKGQGSGVPSRFSGS

IGLV5-37

76

A0A075B6J1
RGFGAGRSQSVSEGP

DCC

1291

P43146
SSGGLANPTRAGGRE

NRXN1

366

P58400
SPGGGGRAGSTLRNS

KCND1

616

Q9NSA2
VRPLNGGAGFAGSSA

KRT28

21

Q7Z3Y7
GPGFRGLGSFGSRSV

KRT84

41

Q9NSB2
KVRFDANGATGPGSR

GPR162

366

Q16538
PSSGTGRGRLFCGDV

HHIPL1

406

Q96JK4
GIPARFSGSGSGTDF

IGKV3D-7

81

A0A0C4DH55
SCGPRIAVGGFRAGS

KRT85

61

P78386
RSDSGGRGELGQPSG

LRIG3

26

Q6UXM1
GAGRGSRSRQPDSGV

HMCN2

831

Q8NDA2
FRLTGSSGFVTDGPG

ATRN

136

O75882
GSNRASGVPDRFSGS

IGKV2D-28

76

P01615
GRRTNPFGESGGSTK

APPL1

476

Q9UKG1
STQRPGSDTVGGGRG

MCM3AP

1001

O60318
TTIGFGNISPRTEGG

KCNK2

156

O95069
YSRQGARPGGGNTVR

GDF10

86

P55107
EGSKRPSGVSNRFSG

IGLV2-23

71

P01705
SFRGIGGTASLEEGP

KIF27

456

Q86VH2
VFSRDSRSSGGPGAG

PLXNB2

296

O15031
GGQRPTGLGSEFFRL

FAM157A

141

C9JC47
TANRSGPFATGVAGG

FCRL5

841

Q96RD9
LVFGSGSAAGRGPTI

LENG9

166

Q96B70
GGGSSRRFEAENGPT

PDE4A

101

P27815
GGNPDRVTIFGESAG

CES2

216

O00748
SLQGRGATSGRPAGE

MINDY1

441

Q8N5J2
AVGDGSSGSQPREGR

EXPH5

1471

Q8NEV8
SSGSQPREGRGDIGT

EXPH5

1476

Q8NEV8
QSFAERSGRGPFGDS

ARSA

236

P15289
DPLRITVFGSGAGGS

NLGN1

291

Q8N2Q7
SSGGLANPTRAGGRE

NRXN1

1371

Q9ULB1
PGSFRVRASSDGEGT

IRS1

321

P35568
QAGFFSTPGGASRDG

EXOC8

136

Q8IYI6
TTPSVYGGAGGRGIR

KRT20

31

P35900
SGIGTGPGVIQDRFS

EIF4G2

381

P78344
GSARALAPGFGSERG

INSM2

451

Q96T92
AQGGGPATAFRVDGD

ITGB4

1681

P16144
GFPLGAARSATGARS

ECEL1

36

O95672
PGATNGSLGRSDGVA

EPS8L2

11

Q9H6S3
GQGPAQGRGTVVRSS

MYO15B

1061

Q96JP2
FDSTRGSGGGQRREA

DNAJA2

376

O60884
RARTSSFAEPGGGGG

GSK3A

16

P49840
GNNGGVSRVSPVSRG

KCNA6

206

P17658
QALVFGGGPGRTSSE

BORCS6

21

Q96GS4
GSSRAAFPQGGRGRG

CPSF6

191

Q16630
PRGFQGMAGARGTSG

COL20A1

1151

Q9P218
GLQGGSAGSPARFTI

FLNA

1076

P21333
SRAEAGSGGPGFTFT

DNAJB2

81

P25686
VGSGSRFLQDPAGSG

CDHR3

391

Q6ZTQ4
SLSGRPRSCDVGGGN

CRTC3

236

Q6UUV7
GRARGVFAGTNTGPN

BCLAF1

806

Q9NYF8
GRRPSGLGSTDSGQE

CACNA1I

561

Q9P0X4
QKGVQGSPSSRGSRG

COL6A5

1541

A8TX70
GAGGPRGSSGRQERS

CCDC102A

221

Q96A19
RASGGGGRAENPQST

DMRTA1

171

Q5VZB9
GPSGASGRDNSRGRD

CPD

201

O75976
EGTEQAPFLGSRGGA

DIDO1

1871

Q9BTC0
SPRRDGSGGGGIYSV

BRSK1

676

Q8TDC3
RGGTSGGPRANSRAG

CAPRIN2

926

Q6IMN6
FEQGTRRVGPSSGDA

LUZP1

971

Q86V48
GSNRASGVPDRFSGS

IGKV2-28

76

A0A075B6P5
GASSRATGIPDRFSG

IGKV3-20

71

P01619
GGGFDRASGSFVAPV

CBLN3

106

Q6UW01
RGRQAGVCFGDSGSP

ELANE

191

P08246
TTASPLRDGFGGQDG

EGLN2

71

Q96KS0
ATSAPGNARFGQGSG

DMBT1

1426

Q9UGM3
VPGFGAGADEGVRRS

ELN

606

P15502
EGGAVRAGGAARPVS

SAMD1

236

Q6SPF0
NRTGPEGYSVGRGGR

DDX43

36

Q9NXZ2
RAFVGEVGARSAAPG

FTCD

341

O95954
GPGETAQRLSGVFAG

LIPE

326

Q05469
RELSFGRGSTAPVGG

PDIA6

386

Q15084
SEQYRGDGIAARGPG

BCKDHA

276

P12694
GGLAQPNFEREGGST

MN1

596

Q10571
PNFEREGGSTGAGRL

MN1

601

Q10571
GNRASSSGFPGARAT

MAP3K1

6

Q13233
PGRGRFGEVTSASNC

SARS2

411

Q9NP81
GDRNGSPGGTGMRNT

STARD13

166

Q9Y3M8
SRRVADGGGAGGTFQ

SRPRB

6

Q9Y5M8
GEVGLDFSPRFAGTG

TATDN3

106

Q17R31
LRPAGGGGSTFEDAV

TBC1D25

471

Q3MII6
EPGDVSARTRSGGGG

SCHIP1

121

P0DPB3
AVTPFSLRGDNDGGG

MYC

76

P01106
TVAAGGGSRLFFRSG

OPLAH

351

O14841
EPGEGGTRFGARSRA

PPP1R3E

41

Q9H7J1
GPFGSRRSSAIGIEN

RAP1GAP

491

P47736
REQGSQRPSVGGSGF

SHROOM3

791

Q8TF72
GANGGTRGTQRGDET

SHROOM3

1191

Q8TF72
RESVEGSGRSGGSPF

SAMD14

221

Q8IZD0
FRGSSDLPFGAVGGT

SETD1B

346

Q9UPS6
IGAVGPTGRGVTEFF

SPTLC3

341

Q9NUV7
GGRATPGVFRSLSGG

TMEM151A

411

Q8N4L1
SPGAASGGGDNRTLV

SSTR5

16

P35346
GFGGQSRGSRPSDAR

SAFB

896

Q15424
DGRGRVSARFGGSPS

SNED1

1251

Q8TER0
RGQGSGAPGSLASVR

SHANK1

41

Q9Y566
DAPVSGGVGAARSGN

HIBADH

156

P31937
LRFRTGSGQGPSSTG

AHNAK2

326

Q8IVF2
DSGGARRSVIGSGPQ

ACSL6

66

Q9UKU0
GSFPRRGFVNGSRES

APC

116

P25054
PAGSGGRNLTTLGIF

CHST2

236

Q9Y4C5
RQTGRGTSFFPTAGG

CLSPN

791

Q9HAW4
SRDGGAASPATEGRG

CLASP1

1216

Q7Z460
GAGEGAVTFPERRGD

C11orf96

171

Q7Z7L8
GNETSFVPSRRSGGR

MYH11

1931

P35749
GPSERGGGRARGTFQ

THRAP3

821

Q9Y2W1
QRPFLIGVSGGTASG

UCK1

21

Q9HA47
GAVVSGIGSGERFFP

WDFY3

1081

Q8IZQ1
DSGGASGRSTPLFGR

SPEG

2476

Q15772
SNRRFSIPESGQGGT

RIPK3

311

Q9Y572
AGAQFGGSGLEDRPS

TCF3

41

P15923
EGQDSPGGQSRGATR

PLCH2

601

O75038
EGVAGGPGFVRRSSS

PLCH2

1326

O75038
LSEQRGSFSDGGDGP

THSD1

471

Q9NS62
GEGPGGAFARVSDSI

WASH2P

431

Q6VEQ5
SARSRGQEKGSPSGG

SRRM4

301

A7MD48
GEGPGGAFVRVSDSI

WASHC1

431

A8K0Z3
ERGFGSATRTGQDRP

VWA2

431

Q5GFL6
PTRVVGGFGAASGEV

TMPRSS9

501

Q7Z410
GSQSGPGDSAYGVRR

SEMA6C

576

Q9H3T2
EGGGSRRSRSAPAQG

SPTBN4

2391

Q9H254
GIFPRDRGSQGGSST

SYT10

36

Q6XYQ8
EGNRGNSSSYRGPGQ

YLPM1

1011

P49750
DSRSSSGFVGLRNGG

USP24

1681

Q9UPU5
GLTRGPGAFVSGVSR

VPS13B

3681

Q7Z7G8
SRDDLVAGPGFGGAR

ZDHHC8

606

Q9ULC8
PRGGQRVGSKTASFA

WNK2

2276

Q9Y3S1
VSAESGVPTFRGAGG

SIRT5

61

Q9NXA8
VNSGAVGNSEPGFRG

TUT4

1561

Q5TAX3
GRPGEGRGNTATETT

SMTN

636

P53814
GGPRAAVQRSTSFGV

SMTN

781

P53814
TEGGGVFTARPAGAL

TYSND1

261

Q2T9J0
GQSLGPRAGRSRDSG

TTLL1

401

O95922
NVSGQDRIGPGSGFS

TNRC6B

286

Q9UPQ9
TGGGSFSQQPSRRGL

ZAR1

146

Q86SH2
AGEQRSGASDGERGP

ZAR1

201

Q86SH2
GSRNYDAFGGPSTGR

ZNF326

186

Q5BKZ1
FSRGGEPDGGKISNF

MYO1F

176

O00160
GGGTRSVTFSRGFGD

MYO1F

886

O00160
TGGPASGRSSKNRDG

NDE1

286

Q9NXR1
NSGIGEGAPRSFSAR

GRIN1

616

Q05586